Aptalis

From Wikipedia, the free encyclopedia
  (Redirected from Axcan Pharma)
Jump to: navigation, search
Aptalis
Type Private
Industry Pharmaceutical
Headquarters Birmingham, Alabama, United States
Key people Dr.Frank A.G.M. Verwiel
Owner(s) TPG Capital
Employees 480[1]
Website www.aptalispharma.com

Aptalis is a privately held, Birmingham, Alabama and Montreal-based, specialty pharmaceutical company that develops, manufactures, markets and distributes a broad line of gastrointestinal (GI) and specialty products, primarily in North America and Europe. Aptalis has manufacturing sites in Canada, Italy, the US, and France.

[edit] History

Aptalis was formed in 2011 after the acquisition of Eurand Pharmaceuticals by Montreal-based Axcan Pharma.[2] [3]

Axcan's traditional focus was on gastrointestinal drugs. Formerly traded publicly on NASDAQ, Axcan was acquired by TPG Capital in 2008. [4] Aptalis continues to be held by TPG.

Eurand Pharmaceuticals was a producer and contract manufacturer of modified release or taste-masked pharmaceutical dosage forms. Eurand's existing manufacturing facilities in Vandalia, Ohio and Milan, Italy continue to operate under the Aptalis name.

[edit] References

[edit] External links

Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Languages